Cytokine Signalling Forum
Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:10:25
- Mais informações
Informações:
Sinopse
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, he discusses two papers: risk of MACE in patients with RA treated with JAKis compared to bDMARDs from the “JAK-pot” study, and the efficacy and safety of zimlovisertib, ritlecitinib and tofacitinib, alone and in combination, in patients with RA and an inadequate response to MTX.
